PTC THERAPEUTICS, INC.

Profile

Company Names

PTC THERAPEUTICS, INC.

Addresses

PTC THERAPEUTICS, INC., 100 CORPORATE COURT, SOUTH PLAINFIELD, NJ 07080

100 CORPORATE COURT, SOUTH PLAINFIELD, NJ 07080-2449

Phone Numbers

908-222-7000
9082227000

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$483,352,028.00

Number of Funding Rounds:

10
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
10
2023-04-10 
$35,897,425.00 
$35,897,425.00 
$0.00 
Equity 
9
2020-05-29 
$41,905,000.00 
$41,905,000.00 
$0.00 
Equity 
8
2020-04-29 
$140,949,151.00 
$140,949,151.00 
$0.00 
Equity 
7
2018-08-23 
$150,000,000.00 
$150,000,000.00 
$0.00 
Equity 
6
2013-05-14 
$4,500,000.00 
$4,500,000.00 
$0.00 
Equity 
5
2013-03-07 
$59,999,448.00 
$59,999,448.00 
$0.00 
Equity 
4
2013-01-29 
$2,000,100.00 
$16,100,100.00 
$14,100,000.00 
Debt 
3
2012-05-29 
$22,950,840.00 
$40,000,000.00 
$17,049,160.00 
Equity 
2
2009-12-22 
$25,150,064.00 
$50,300,000.00 
$25,149,936.00 
Equity 
1
2009-09-22 
$0.00 
$1,000,000.00 
$1,000,000.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RICHARD 
 
ALDRICH 
DIRECTOR
LONGWOOD FOUNDERS FUND, L.P.   |  VERASTEM, INC.   |  OVASCIENCE, INC.   |  PTC THERAPEUTICS, INC.   |  MITOKYNE, INC.   |  COLORESCIENCE INC
NEIL 
 
ALMSTEAD 
EXECUTIVE OFFICER
PTC THERAPEUTICS, INC.
NEIL 
 
ALMSTEAD, PH.D 
EXECUTIVE OFFICER
PTC THERAPEUTICS, INC.
WILLIAM 
 
BAIRD, III 
EXECUTIVE OFFICER
PTC THERAPEUTICS, INC.
AXEL 
 
BOLTE 
DIRECTOR
LUX BIOSCIENCES INC   |  KOLLTAN PHARMACEUTICALS INC   |  PTC THERAPEUTICS, INC.   |  OPHTHOTECH CORP.   |  ALLENA PHARMACEUTICALS, INC.   |  NABRIVA THERAPEUTICS PLC   |  INOZYME PHARMA, INC.
MARK 
E. 
BOULDING 
EXECUTIVE OFFICER
PTC THERAPEUTICS, INC.
SOREN 
 
CARLSEN 
DIRECTOR
PTC THERAPEUTICS, INC.
CARL 
 
GOLDFISCHER 
DIRECTOR
BRAINCELLS INC   |  ENTEROMEDICS INC   |  METABOLEX, INC.   |  PTC THERAPEUTICS, INC.   |  PHARMAKEA, INC.   |  SYNGEN INC.   |  SIDECAR THERAPEUTICS, INC.   |  IMARA INC.   |  GALECTO, INC.
EMILY 
 
HILL 
EXECUTIVE OFFICER
PTC THERAPEUTICS, INC.
CLAUDIA 
 
HIRAWAT 
EXECUTIVE OFFICER
PTC THERAPEUTICS, INC.
ALLAN 
S. 
JACOBSON 
DIRECTOR
PTC THERAPEUTICS, INC.
ALLAN 
 
JACOBSON, PH.D. 
DIRECTOR
PTC THERAPEUTICS, INC.
MATTHEW 
 
KLEIN 
EXECUTIVE OFFICER
INTERNATIONAL AG INSURANCE SOLUTIONS, LLC   |  REDROCK CAPITAL FUND II, LLC   |  REDROCK CAPITAL FUND III, LLC   |  DIRTJOCKEY, INC.   |  REDROCK CAPITAL FUND IV, LLC   |  REDROCK CAPITAL FUND V, LLC   |  LIEN NATION, LLC   |  COLLECTIVE2 HOLDINGS LLC   |  BACKBONE PLM, INC.   |  PTC THERAPEUTICS, INC.   |  MEMBERSUITE, INC.   |  SWEATER INC   |  GEMA CP FUND I LLC
MATTHEW 
B. 
KLEIN 
EXECUTIVE OFFICER
PTC THERAPEUTICS, INC.   |  CLEARPOINT NEURO, INC.
MATTHEW 
B. 
KLEIN, M.D. 
EXECUTIVE OFFICER, DIRECTOR
PTC THERAPEUTICS, INC.
ADAM 
 
KOPPEL 
DIRECTOR
BROOKSIDE II CAYMAN LTD   |  BROOKSIDE CAPITAL PARTNERS FUND II, L.P.   |  BROOKSIDE CAPITAL PARTNERS FUND LP   |  BROOKSIDE CAYMAN LTD   |  BROOKSIDE CAYMAN PA LTD   |  PTC THERAPEUTICS, INC.   |  VIACYTE INC.   |  SOLID BIOSCIENCES INC.   |  CARDURION PHARMACEUTICALS, INC.   |  ARETEIA THERAPEUTICS, INC.
MICHAEL 
 
KRANDA 
DIRECTOR
PTC THERAPEUTICS, INC.   |  VACCINOGEN INC   |  BEAT BIOTHERAPEUTICS CORP   |  TWINSTRAND BIOSCIENCES, INC.
GEOFFREY 
 
MCDONOUGH 
DIRECTOR
PTC THERAPEUTICS, INC.   |  GENERATION BIO CO.
LANGDON 
L. 
MILLER 
EXECUTIVE OFFICER
PTC THERAPEUTICS, INC.
LANGON 
L. 
MILLER 
EXECUTIVE OFFICER
PTC THERAPEUTICS, INC.
STEPANIE 
S. 
OKEY 
DIRECTOR
PTC THERAPEUTICS, INC.
STEPHANIE 
S. 
OKEY 
DIRECTOR
PTC THERAPEUTICS, INC.
DEEPA 
 
PAKIANATHAN 
DIRECTOR
PTC THERAPEUTICS, INC.   |  NEURAXON(USA), INC.   |  RELYPSA INC   |  CALITHERA BIOSCIENCES, INC.   |  ONCOMED PHARMACEUTICALS INC
ERIC 
 
PAUWELS 
EXECUTIVE OFFICER
PTC THERAPEUTICS, INC.
STUART 
W. 
PELTZ 
EXECUTIVE OFFICER, DIRECTOR
PTC THERAPEUTICS, INC.
EMMA 
 
REEVE 
DIRECTOR
CONSTELLATION PHARMACEUTICALS INC   |  PTC THERAPEUTICS, INC.   |  RIBON THERAPEUTICS, INC.   |  AADI BIOSCIENCE, INC.   |  CARDURION PHARMACEUTICALS, INC.   |  REALTA LIFE SCIENCES, INC.
MICHAEL 
 
SCHMERTZLER 
DIRECTOR
SEGWAY INC   |  KOLLTAN PHARMACEUTICALS INC   |  PTC THERAPEUTICS, INC.   |  SCHEDULICITY, INC.   |  AGNOVOS BIOSCIENCE, INC.
MARY 
 
SMITH 
DIRECTOR
GOGENICS LLC   |  WESTROCK ALPHA FUND, L.P.   |  WESTROCK ALPHA OFFSHORE FUND, LTD.   |  WESTROCK ABSOLUTE RETURN FUND, LP   |  WESTROCK ARCH FUND, LP   |  PTC THERAPEUTICS, INC.
DAVID 
P. 
SOUTHWELL 
DIRECTOR
PTC THERAPEUTICS, INC.
MARCIO 
 
SOUZA 
EXECUTIVE OFFICER
PTC THERAPEUTICS, INC.   |  MRI INTERVENTIONS, INC.
GLENN 
D. 
STEELE JR., M.D., PH.D. 
DIRECTOR
PTC THERAPEUTICS, INC.
GLENN 
D. 
STEELE, JR. 
DIRECTOR
PTC THERAPEUTICS, INC.
PETER 
 
SVENNILSON 
DIRECTOR
FARALLON BIOSCIENCES, INC   |  NGM BIOPHARMACEUTICALS INC   |  COLUMN GROUP II, LP   |  ARAGON PHARMACEUTICALS, INC.   |  PTC THERAPEUTICS, INC.   |  IMMUNE DESIGN CORP.   |  COLUMN GROUP II, LP   |  COLUMN GROUP III-A, LP   |  COLUMN GROUP III, LP   |  CONSTELLATION PHARMACEUTICALS INC   |  CIRCLE PHARMA, INC.   |  CARMOT THERAPEUTICS INC.   |  COLUMN GROUP-NEURO, LP   |  COLUMN GROUP V, LP   |  COLUMN GROUP OPPORTUNITY III, LP   |  COLUMN GROUP SPV I, LP   |  COLUMN GROUP-NEURO II, LP   |  NGM BIO HOLDINGS, INC.   |  NEURONA THERAPEUTICS, INC
DAWN 
 
SVORONOS 
DIRECTOR
PTC THERAPEUTICS, INC.   |  AGNOVOS BIOSCIENCE, INC.   |  ADVERUM BIOTECHNOLOGIES, INC.
CHRISTINE 
 
UTTER 
EXECUTIVE OFFICER
PTC THERAPEUTICS, INC.
ALETHIA 
 
YOUNG 
DIRECTOR
PTC THERAPEUTICS, INC.   |  BICYCLE THERAPEUTICS PLC
JEROME 
B. 
ZELDIS 
DIRECTOR
PTC THERAPEUTICS, INC.   |  ADVANCED INHALATION THERAPIES (AIT) LTD.   |  AIT THERAPEUTICS, INC.   |  METASTAT, INC.   |  NEXGELRX, INC.
JEROME 
B. 
ZELDIS, M.D., PH.D. 
DIRECTOR
SOLIGENIX, INC.   |  PTC THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-05-08
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-04-10 
2020-06-12
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-05-29 
2020-05-14
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-04-29 
2018-09-05
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-08-23 
2013-05-15
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2013-05-14 
2013-03-21
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2013-03-07 
2013-02-12
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2013-01-29 
2012-06-13
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-05-29 
2009-12-22
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$25,000,001 - $100,000,000 
Equity 
2009-12-22 
2009-10-07
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$25,000,001 - $100,000,000 
 
2009-09-22 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
SVB LEERINK LLC
39011
NONE
NONE
CREDIT SUISSE SECURITIES (USA) LLC
816
NONE
NONE
WEDBUSH SECURITIES INC.
877